Rituximab for HTLV-1-associated Myelopathy
Clinical trial NCT04004819 · UNKNOWN
Trial details
- NCT number
- NCT04004819
- Sponsor
- First Affiliated Hospital of Fujian Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-15
- Primary completion
- 2023-07-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.